Recurrent Early Pregnancy Loss

Similar documents
Recurrent Early Pregnancy Loss

Anatomic factors and recurrent pregnancy loss. M. Goddijn and C.R. Kowalik

Medical Affairs Policy

Disclosure. Dagan Wells University of Oxford Oxford, United Kingdom

Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC

Chromosomal Structural Abnormalities among Filipino Couples with Recurrent Pregnancy Losses

Neil Goodman, MD, FACE

Prior Authorization Review Panel MCO Policy Submission

Preimplantation Genetic Testing

New methods for embryo selection: NGS and MitoGrade

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

RECURRENT PREGNANCY LOSS

Index. Note: Page numbers of article titles are in boldface type.


PD Dr. med. habil. Michaela Jaksch, Consultant Laboratory Medicine, Medical Director, Freiburg Medical Laboratory ME LLC, Dubai, UAE

Problem Challenge Need. Solution Innovation Invention

INDICATIONS OF IVF/ICSI

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Reproductive Endocrinology and Infertility Rotation Objectives. Reproductive Endocrinology and Infertility Specialists

Infertility: A Generalist s Perspective

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

Infertility treatment other than ART. Dr. Prue Johnstone FRANZCOG MRepMed

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

Data collected through IVF- Worldwide.com

Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women

Application of OMICS technologies on Gamete and Embryo Selection

Index. laboratory interventions emerging treatment options, freeze-all strategy, 67 vitrification, 68 morphologic features, 66

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Recent Developments in Infertility Treatment

Rejuvenation of Gamete Cells; Past, Present and Future

A Tale of Three Hormones: hcg, Progesterone and AMH

An Overview of Uterine Factors That Influence Implantation

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS

NEW PATIENT CONSULTATION CLINICAL QUESTIONNAIRE

Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY

A Stepwise Approach to Embryo Selection and Implantation Success

Patient Price List. t: e: w:

IN VITRO FERTILISATION (IVF)

Subfertility/Infertility Assessment in the Medical Laboratory

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Thrombophilia. Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC. GASCO Atlanta Sept 8 th, Disclosures. Conflicts of interest: NONE

Treatment Plan Page1 TREATMENT PLAN TREATMENT PLAN TYPE TREATMENT PLANNED. New Update Management Review Committee

FU Consultation Note Page1

Original Policy Date

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

Thyroid Autoantibodies as a Marker of Immunologic Disorder in Women with Unexplained Recurrent Spontaneous Abortion

Infertility History Form

PRICE LIST OF THE CLINIC OF REPRODUCTIVE MEDICINE AND GYNAECOLOGY IN ZLIN This price list is valid from

Medical Policy Preimplantation Genetic Testing

Metformin in early pregnancy and abortions. Laure Morin-Papunen, MD, PhD Dept. of Obstetrics and Gynecology University Hospital of Oulu, Finland

Freeze-All Policy: Is It Right for Everyone?

Pre-Treatment (For all treatment types) Initial Consultation 120 Planning Consultation 150 Follow Up Consultation 75

PGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis

The major causes of female infertility include ovulatory dysfunction, tubal and peritoneal

Acacio Fertility Center, Inc. Brian Acacio, MD Mission Viejo Laguna Niguel Bakersfield. Name of Patient DOB Age. Name of Partner DOB Age

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Current View of the Treatment of Antiphospholipid Syndrome

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Hold On To Your Dreams

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

The Impact of Insulin Resistance on Long-Term Health in PCOS

Novel Technologies for Selecting the Best Sperm for IVF and ICSI

Prevalence of thyroid disorder in pregnancy and pregnancy outcome

Grand Rounds Mullerian Anomalies. Sara Schaenzer, PGY-3 9/26/18

Information for couples with Recurrent Pregnancy Loss

Abstract. Introduction

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

IMJM. Combined Hysteroscopy and Laparoscopy in the Evaluation of Patients with Recurrent Pregnancy Loss. THE INTERNATIONAL MEDICAL JOURNAL Malaysia

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Current Update on Recurrent Pregnancy Loss

Chromosomal Aneuploidy

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Hepatitis C: what do you need to know if trying to conceive

RIC Information for Patients

Surgical Management of Endometriosis associated Infertility

Isolated Choroid Plexus Cyst

American Journal of Human Genetics. American Journal of Hypertension. American Journal of Neuroradiology

Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients

PRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

NEW PATIENT DATA SHEET Please complete as best you can. It is not necessary to have all information before speaking with a doctor. PATIENT INFORMATION

The effects of PGS/PGT-A on IVF outcomes

Ideal preparation for pregnancy

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

Dr.Shobha N Gudi. Prof. and HOD. Dept of OBG. St. Philomenas Hospital, Dr Malathi Manipal hospital, Excel Care, Sagar Chandramma Hospitals, Bangalore.

Diagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics

Number of oocytes and live births in IVF

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

RECURRENT PREGNANCY LOSS. Guideline of the European Society of Human Reproduction and Embryology

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

Obstetric complications and management in women with polycystic ovary syndrome

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?

INFERTILITY SERVICES

Clinical aspect of endometrial injury!

Progesterone and clinical outcomes

Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation

Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions

Transcription:

Recurrent Early Pregnancy Loss and the Role of Ultrasound Charles J. Lockwood, M.D. Dean, of the College of Medicine and Vice President for Health Sciences, The Ohio State University

Introduction Recurrent Abortion (RAB) Only 2% of pregnant women experience 2 consecutive pregnancy losses Only 0.4 experience 3 consecutive losses Population-based probabilities of 2 and 3 consecutive losses are 4% and 0.4%, respectively! After 2 or 3 SABs, the subsequent miscarriage rate is 26% and 32%, respectively Lancet 1990; 336:673-5. Reprod Nutr Dev 1988; 28:1555-68.

Definition ASRM defines es RPL as 2 or more failed pregnancies (documented by US or histological exam) and suggests some assessment after each loss with a thorough evaluation after three or more losses. Need to consider whether losses are embryonic or fetal, primary or secondary, and whether they are related to AMA.

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract Anomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Genetic Abnormalities: Chromosomal Abnormalities Prevalence with recurrent SABs: 50% SAB correlate with maternal age related Maternal Age SAB rate <30 years <12% 30-34 15% 35-39 25% 40-44 50% >44 >90% Hum Reprod 1998; 13:805-9. Postgrad Obstet Gynecol 2000; 20:1

Chromosomal Abnormalities Etiology: Gamete aging Decreased Telomerase activity leads to shorter telomeres causing abnormal chiasma formation, in turn, leading to abnormal meiotic synapsis and/or non- disjunction. Keefe et al. Am J Obstet Gynecol. 2005; 192:1256-60; Liu et al. Proc Natl Acad Sci. 2004; 101:6496-501

Chromosomal Abnormalities Etiology: Gamete aging Transcriptional silencing begins with oocyte maturation and persists during initial mitotic divisions of the embryo. Gene expression during this period largely depends on the translational activation of maternal mrnas by cytoplasmic polyadenylation and requires an embryonic poly(a) binding protein (EPAB).

Chromosomal Abnormalities Etiology: Gamete aging embryonic poly(a) binding protein (EPAB_ plays a central role in the regulation of oocyte maternal-derived d mrna activation by preventing deadenylation and promoting translation. Decreased EPAB levels may lead to decreased readenylation of dormant oocyte mrna and thus, failure of translation of key meiotic proteins poe swith resultant non-disjunction. dsju o (Mol Hum Reprod. 2008;14:581-8; and E. Seli, Yale University, personal communication)

Chromosomal Abnormalities Etiology: Non-age related parental factors Fragile sites on chrom. Inversions (9) p11q12. Balanced translocations (3.5-4.4%). Fertil Steril 1999; 71(4):726-31. Hum Reprod 1990; 5(5):519-28. Fertil Steril 1996; 66(1):24-9. Acta Eur Fertil 1989; 20(6):367-70. Mutat Res 1998; 417:47-55. Am J Med Genel 1984; 17: 615-20. Curr Opin Obstet Gynecol 1994; 6:153-9. Am J Obstet Gynecol. 2001; 185:563-8.

Chromosomal Abnormalities Etiology: Metabolic factors Women with low ( 2.19 ng/ml) folate levels are at increased risk of SAB (OR of 1.47; 95%CI: 1.01-2.14) Low folate levels associated with a significantly increased risk of SAB due to aneuploidy (OR of 1.95; 95% CI: 1.09-3.48) but not euploid losses (OR of 1.11; 95% CI: 0.55-2.24). JAMA 2002; 288:1867-73; J Obstet Gynaecol. 2003; 23:55-8; Obstet Gynecol. 2000; 95:519-24.

Chromosomal Abnormalities Potential Treatments Folate and B 6 Donor Egg IVF

Chromosomal Abnormalities Potential Treatments IVF with PGD conflicting results with both AMA-associated RAB and those related to parental balanced trans- locations Rubio et al. Am J Reprod Immunol. 2005; 53:159-6; Platteau et al. Fertil Steril. 2005; 83:393-5; Sugiura-Ogasawara et al. Hum Reprod. 2005; 20:3267-70.

Genetic Abnormalities: Mendelian disorders 1) Fetal single gene defects may promote RAB. Lethal multiple pterygium syndromes (AR/X- LR) associated with fetal death at 14 to 20 weeks & arthrogyposis, hydrocephaleus, hydrops & cystic hygromas (Am J Obstet Gynecol. 1988; 159:474-6). Incontinentia pigmenti (X-LR) lethal in males who develop hydrops and cystic hygromas; affected females have epidermal anomalies (J Gynecol Obstet Biol Reprod.. 1997; 26:633-6). Homozygosity for AD polycystic kidney disease (PKD1 and PKD2) is an embryonic lethal. (Patterson et al, Am J Kidney Dis. 2002; 40:16-20)

Mendelian disorders 2) Maternal single gene defects may promote RAB due to endometrial abnormalities. Frequency of homozygosity of the VEGF -1154 A/A gene associated with recurrent implantation failure (19% versus 5%, P = 0.02).(Goodman 02) et al, Reprod Biomed Online. 2008; 16:720-3) Maternal p53 72 polymorphism linked with implantation failure. (Kay et al, Reprod Biomed Online. 2006; 13:492-6)

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Infectious Disease No consistent association between Recurrent SAB and either chlamydia or mycoplasma species Am J Obstet Gynecol 1994; 170(3):782-5. Obstet Gynecol 1983; 62(5):574-81. Br J Obstet Gynecol 1984; 91(12):1177-80.

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract Anomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Mullerian Tract Anomalies Women with > 3 consecutive unexplained SABs have a higher h rate of major mullerian anomalies than controls 23.8% vs. 5.3% using 3-DUS(Hum3 D Reprod. 2003; 18: 162-6.54). However, in both groups the most common anomalies were arcuate and subseptate uteri, which may not be associated with higher rates of recurrent SAB (Hum Reprod. 1997; 12:2277-81).

Mullerian Tract Anomalies Submucous myomas which distort the uterine cavity have been posited as causes of RAB and reduced IVF success rates (Hum. Reprod. 2000; 6: 614-20). But no RCTs to confirm the benefits of hysteroscopic repair (Best Pract Res Clin Obstet Gynaecol. 2008;22:749-60).

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract Anomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Endocrine Causes: DM and Thyroid disease No association between sporadic or recurrent SABs and well-controlled diabetes and subclinical hypothyroidism Probable link with anti-thyroid thyroid antibodies but uncertain treatment options (?Synthyroid). Lancet 1990; 336:728-33; N Engl J Med 1988; 319:1617-23; Eur J Endocrinol. 2010;162:643-52.

Endocrine Causes: PCOS Conflicting data on the association between SABs and PCOS and whether Metformin reduces risk. (J Clin Endocrinol Metab. 2002;87:524-9; Hum Reprod. 2002; 17:2858-64Hum Reprod. 2000; 15:612-5; Aust N Z J Obstet Gynaecol. 1997; 37:402-6) Among PCOS patients randomized to clomid, metformin or both, rates of SABs did not differ significantly among the groups. (Legro et al. N Engl J Med. 2007; 356:551-66)

Endocrine Causes: LPD Prevalence of LPD among RAB patients reported to be between 10 and 30% (Curr Opin Obstet Gynecol. 2005; 17:424-8). No definitive diagnostic criteria since the condition is intermittent (Curr( Opin Obstet Gynecol. 1994; 6:121-7). Meta-analysis analysis of trials of progesterone therapy for RAB do not demonstrate a benefit (Cochrane Review, Issue 3, 2004. Oxford).

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Alloimmune losses (?) () Maternal tolerance of fetal allograft is mediated by trophoblast expression of non-immunogenic HLA-G Fas ligand immunosuppressive agents: hcg, PAPP-A, progesterone, and cortisol Am J Reprod Immunol 1998; 40: 136-44. J Clin Endocrinol Metab 1996; 81:3119-22.

Alloimmune losses (?) () Theories and Diagnostic tests Absence of maternal-anti-paternal p leukocyte blocking antibodies. Excess circulating activated Natural Killer cells (CD57+ NK) J Soc Gynecol Invest 1997; 4: 267-73; Hum Reprod 1996; 11:1569-74; Am J Reprod Immunol 1999; 41:91-8.

Alloimmune losses (?) Diagnostic tests (cont.) Patients without maternal-anti-paternal leukocyte antibodies have normal pregnancies and patients with antibodies can miscarry. We have shown decidual NK cells express a very different repertoire of genes than those in the circulation. There is growing evidence that NK cell activity actually PROMOTES normal placentation. J Exp Med. 2003;198:1201-12; J Exp Med. 2004; 200:957-65

Alloimmune losses Treatments: Meta-analysesanalyses of Paternal/3 rd Party leukocyte immunization (ratio of live births in Tx/Ctr groups) show no consistent benefit: 1.16 (95% Cl 1.01-1.34, P=0.03) 1.21 (95% Cl 1.04-1.37, 1.37, P=0.02) 1.3 (95% Cl 0.77-2.3) 1.3(95%Cl044-3 0.44-3.8) Am J Reprod Immunol 1994; 32:55-72; Obstet Gynecol 1993; 82:854-9.

Alloimmune losses Design: Double-blind, multi-centered RCT of Paternal WBC immunization (n=91) vs. saline placebo (n=92). Outcome: Success rate was 31/86 (36%) in treatment t t group and 41/85 (48%) in the control group (OR 0.60, 95% Cl: 0.33-1.12; ;p p=0.108). Lancet 1999; 354: 365-9.

Alloimmune losses Treatments: Meta-analyses of IVIG Rx OR 1.48 (95% Cl, 0.84-2.6) Am J Reprod Immunol 1998; 39:69-76. Am J Reprod Immunol 1998; 39:82-8. Cochrane Database 1999; 2:1-8.

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Antiphospholipid Antibodies APA s represent a general class of self- recognition Ig s directed against proteins bound to negatively charged surfaces, usually anionic phospholipids. Must be present during two evaluations ations 12 weeks apart and associated with thrombosis or adverse pregnancy outcomes Miyakis et al. J Thromb Haemost. 2006;4:295-306;Galli et al. Hematol J. 2003; 4:180-6; Greaves et al. Lancet. 1999; 353:1348-53.

Antiphospholipid Antibodies They can be identified by searching for antibodies that specifically bind protein epitopes: β-2-glycoprotein-1, prothrombin, annexin V, and others - activated protein C, S and X

Antiphospholipid Antibodies They can be identified by searching for antibodies that bind proteins that bind anionic phospholipids cardiolipin and phosphatidylserine

Antiphospholipid Antibodies They can be identified by searching for antibodies thatt exert tdownstream effects on prothrombin activation in a phospholipid milieu - lupus anticoagulants (LAC).

Antiphospholipid Antibodies Reported ORs for LAC-associated fetal loss range from 3.0 to 4.8 while anti-cardiolipin antibodies (ACA) display a wider range of reported OR s of 0.86 to 20.0 Galli et al Hematol J. 2003; 4:180-6; Greaves Lancet. 1999; 353:1348-53.

Antiphospholipid Antibodies There is conflicting evidence whether APA are also associated with recurrent (> 3) early SAB in the absence of stillbirth: At least 50% of pregnancy losses in APA patients occur after the 10 th week (Lupus 1996; 5:409-13). Compared to patients having unexplained early p p g p y SAB without APA, those with APA more often display fetal cardiac activity (86% vs. 43%; P < 0.01) (Hum Reprod 1995; 10:3301-4).

Antiphospholipid Antibodies There is conflicting evidence whether APA are also associated with recurrent (> 3) early SAB: Meta-analysis Mt l i shows no association between APA and either IVF clinical pregnancy (OR 0.99; 0.64 1.53) or live birth rates (OR 1.07; 0.66 1.75) (Fertil Steril. 2000; 73:330 3). Treatment of APA does not improve IVF success rates (Fertil Steril. 2003; 80:376-83). ( ; )

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Müellerian Tract Anomalies Arcuate uterus Partial septum Complete septum

The viability rules (via TVS) When Yolk Sac (YS) size= 5 mm, fetal pole should be visible. If YS > 6mm = poor prognosis. Fetal pole >5 mm should = positive FHR. Mean Sac Diameter (MSD) >12 mm and no YS = anembryonic gestation. MSD > 20 mm and no fetal pole = anembryonic gestation. Gldti Goldstein s rule: Gestational ti age (days) = early embryonic size (mm) + 42 {up to 25 mm} (Laing et al. Evaluation During the First Trimester of Pregnancy. In: Ultrasonography in Obstetrics and Gynecology, 4th ed, Callen, PW (Ed), WB Saunders, Philadelphia 2000; Rowling et al. AJR Am J Roentgenol 1999; 172:983; Grisolia et al. Ultrasound Obstet Gynecol 1993; 3:403; Goldstein and Wolfson R. J Ultrasound Med 1994; 13:27)

Yolk Sac

Measurement of Embryo in GS

Anembryonic Gestation

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment

Recurrent Early Pregnancy Loss No real evidenced-based work-up and treatment but I recommend: 1) Parental karyotypes and/or assessment of abortus karyotype. 2) If parental chromosomal abnormalities present (e.g., g translocation) consider IVF ± PID.

Recurrent Early Pregnancy Loss 3) When karyotypes of abortus specimens are euploid, the patients losses are intermittent and generally occur at the same gestation ti age analyze placentas of prior losses for trophoblast inclusions. (J Theor Biol. 2003; 225:143-5) 4) If single gene disorders are suspected, Yale offers exon genomic sequencing of POCs. Should this detect a developmentally lethal mutation present in both parents (due to AR inheritance +/- germ line loss of heterozygosity), offer IVF with PGD. 5) If maternal endometrial implantation disorders are suspected (e.g., recurrent primary losses in a young patient) consider surrogacy (gestational carrier).

Recurrent Early Pregnancy Loss 6) Evaluate uterus with sonohysterography and 3-D US and with hysteroscopic repair of remediable defects prior to conception. 7) Rule-out APA (LAC, ACA, anti-ß2- glycoprotein-i). If positive x 2 at least 12 weeks apart, treat with LMWH, and LDA in subsequent pregnancy.

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias APA Work-up and Treatment

Recurrent Early Pregnancy Loss Genetic Abnormalities Infectious Diseases Mullerian Tract tanomalies Endocrine Causes Alloimmune Losses Thrombophilias Use of Ultrasound Work-up and Treatment